Nonvascular retinal imaging markers of preclinical Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

http://www.wikidata.org/entity/Q37363628

about

Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis.Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.Impaired retinal microcirculation in patients with Alzheimer's disease.Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.Emerging Applications of Optical Coherence Tomography Angiography (OCTA) in neurological research.Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease.Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview Principles of OCTA and Applications in Clinical Neurology

P2860

Q30235369-DF8079CC-3DE6-44BE-BDCF-A1F3697BD6DA Q37670223-BB636AF3-F45B-4814-868C-C7C385D524A2 Q47221811-8F4DBB9B-AA53-4CAF-BB24-BF8941B4446E Q47549495-6E53A354-0A2A-494E-8B88-BA9329A905EC Q47738091-07AD51CA-3D73-42AB-82FA-F5F326C9F000 Q51760905-FF2F4A7E-A444-457A-8CE3-15530F57CA7C Q55004366-88FD7875-FA0D-426F-B76D-12451175B702 Q55026294-F11A5086-F6C0-4AFD-B302-354C664449D8 Q58567916-9D1CD71F-A938-4966-9C0E-B81137C8C0F3 Q58594830-4C198BE8-3B1F-43BD-89DC-751F05F00EC0

P2860

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

http://www.wikidata.org/entity/Q37363628

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@en

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@nl

type

label

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@en

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@nl

prefLabel

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@en

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@nl

P1433

Q37363628-0E9632E2-8479-456D-93BF-85B85E63238E

P1476

Q37363628-BB1944B9-354B-41B9-8C20-9B53279CE94F

P2093

Q37363628-031F2B72-94E4-4EC7-A58F-8BA96080E261

Q37363628-8C292BA3-54AE-43C3-ACE0-9AEB4A32C3AF

Q37363628-9572011A-0884-417C-9974-4010D623966E

Q37363628-CAED4F95-FFD7-49AE-8A55-B4617F0106EB

Q37363628-FDFD8184-2530-434B-9210-E1118D924604

P2860

Q37363628-05A2D4E5-745B-4897-9095-4F3693C435C8

Q37363628-06E18E25-77E4-4284-A1ED-24F9D6EA7523

Q37363628-0F1EB6EF-9B7B-4172-A963-636C626AF0CC

Q37363628-197F5FE9-8209-4ED6-9C76-36B5B6815DCE

Q37363628-1981AEC5-6D23-440D-9A40-D6DF1290B954

Q37363628-198B299D-8AAB-4D18-AA76-1B23E9808127

Q37363628-1A065F01-C1B6-4C6B-8C1D-4B6A2FA1A3A6

Q37363628-20388B9A-9243-4AAD-9CDD-B3B6385A9324

Q37363628-25E360E3-DCA3-477B-ABA3-45D59F84A538

Q37363628-273363A4-A3F4-4AC8-BB48-4A4CA3FC6FBD

P304

Q37363628-0C035683-64D3-4826-BD4D-D820844E8AC7

P31

Q37363628-A8F380FC-D53B-4F55-96ED-076758684ACB

P356

Q37363628-BE207BF8-6E6C-43EB-B101-380B5A4330EF

P478

Q37363628-6FDAFAFE-5721-4F83-93E2-626215B103B6

P50

Q37363628-6CB4C52E-314E-4E11-A6EE-AEACCCCC4E47

Q37363628-D8CF53EB-7331-4471-B704-B7EEE96CAC36

P577

Q37363628-FE4557C0-ABA2-4AE6-B52A-F03415509987

P698

Q37363628-A4EFA575-8C17-4134-8960-03F72AE854D0

P921

Q37363628-52412F9F-5F1B-4535-B79B-6157C457E326

P932

Q37363628-0E16B131-13BA-47B7-8EE6-98C8EDD391DD

P356

J.DADM.2016.09.001

P1433

Alzheimer's & dementia (Amsterdam, Netherlands)

P1476

Nonvascular retinal imaging markers of preclinical Alzheimer's disease.

@en

P2093

Brian Fernández

http://www.w3.org/2001/XMLSchema#string

Cláudia Y Santos

http://www.w3.org/2001/XMLSchema#string

Jessica Alber

http://www.w3.org/2001/XMLSchema#string

Lenworth N Johnson

http://www.w3.org/2001/XMLSchema#string

Paul Maruff

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging.

Retinal abnormalities in early Alzheimer's disease.

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.

Soluble and mature amyloid fibrils in drusen deposits

Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.

The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

P304

169-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DADM.2016.09.001

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Peter J. Snyder

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27830174

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5078641

http://www.w3.org/2001/XMLSchema#string